http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 03 Feb 2025 09:00:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Feb+03/24284316.html si-local-file:///var/storage/secattach/20250203/24284316.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Feb+03/24284316.html Mon, 03 Feb 2025 09:00:00 -0500 O.50292072 PROC http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Feb+03/24284316.html si-local-file:///var/storage/secattach/20250203/24284316.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Feb+03/24284316.html Mon, 03 Feb 2025 09:00:00 -0500 O.50292072 PROC http://www.streetinsider.com/Corporate+News/Procaps+Group+%28PROC%29+Receives+Nasdaq+Delisting+Notice/24284166.html <p>Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) that it has determined to delist the Company’s ordinary shares on Nasdaq. The delisting is a result of the Company’s failure to demonstrate compliance with Nasdaq Listing Rules 5250(c)(1) and 5250(c)(2) for failing to file periodic and interim financial reports. As a result of the forgoing, the Company’s ordinary shares are expected to commence trading on the Expert Market operated by the OTC Markets Group, Inc. (“OTC”), http://www.streetinsider.com/Corporate+News/Procaps+Group+%28PROC%29+Receives+Nasdaq+Delisting+Notice/24284166.html Mon, 03 Feb 2025 08:53:58 -0500 PROC http://www.streetinsider.com/Press+Releases/Procaps+Group+Receives+Delisting+Notice+From+Nasdaq/24284137.html <p align="justify">MIAMI and BARRANQUILLA, Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) that it has determined to delist the Company’s ordinary shares on Nasdaq. The delisting is a result of the Company’s failure to demonstrate compliance with Nasdaq Listing Rules 5250(c)(1) and 5250(c)(2) for failing to file periodic and interim financial reports. As a result of the forgoing, the Company’s ordinary shares are expected to commence http://www.streetinsider.com/Press+Releases/Procaps+Group+Receives+Delisting+Notice+From+Nasdaq/24284137.html Mon, 03 Feb 2025 08:50:00 -0500 PROC PROC http://www.streetinsider.com/Press+Releases/Procaps+Group+Receives+Delisting+Notice+From+Nasdaq/24284137.html <p align="justify">MIAMI and BARRANQUILLA, Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) that it has determined to delist the Company’s ordinary shares on Nasdaq. The delisting is a result of the Company’s failure to demonstrate compliance with Nasdaq Listing Rules 5250(c)(1) and 5250(c)(2) for failing to file periodic and interim financial reports. As a result of the forgoing, the Company’s ordinary shares are expected to commence http://www.streetinsider.com/Press+Releases/Procaps+Group+Receives+Delisting+Notice+From+Nasdaq/24284137.html Mon, 03 Feb 2025 08:50:00 -0500 PROC PROC http://www.streetinsider.com/Globe+Newswire/Procaps+Group+Receives+Delisting+Notice+From+Nasdaq/24284137.html <p align="justify">MIAMI and BARRANQUILLA, Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) that it has determined to delist the Company’s ordinary shares on Nasdaq. The delisting is a result of the Company’s failure to demonstrate compliance with Nasdaq Listing Rules 5250(c)(1) and 5250(c)(2) for failing to file periodic and interim financial reports. As a result of the forgoing, the Company’s ordinary shares are expected to commence http://www.streetinsider.com/Globe+Newswire/Procaps+Group+Receives+Delisting+Notice+From+Nasdaq/24284137.html Mon, 03 Feb 2025 08:50:00 -0500 PROC PROC http://www.streetinsider.com/Globe+Newswire/Procaps+Group+Receives+Delisting+Notice+From+Nasdaq/24284137.html <p align="justify">MIAMI and BARRANQUILLA, Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) that it has determined to delist the Company’s ordinary shares on Nasdaq. The delisting is a result of the Company’s failure to demonstrate compliance with Nasdaq Listing Rules 5250(c)(1) and 5250(c)(2) for failing to file periodic and interim financial reports. As a result of the forgoing, the Company’s ordinary shares are expected to commence http://www.streetinsider.com/Globe+Newswire/Procaps+Group+Receives+Delisting+Notice+From+Nasdaq/24284137.html Mon, 03 Feb 2025 08:50:00 -0500 PROC PROC http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Jan+17/24225431.html si-local-file:///var/storage/secattach/20250121/24225431.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Jan+17/24225431.html Tue, 21 Jan 2025 06:00:00 -0500 O.50292072 PROC http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Jan+17/24225431.html si-local-file:///var/storage/secattach/20250121/24225431.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Jan+17/24225431.html Tue, 21 Jan 2025 06:00:00 -0500 O.50292072 PROC http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Jan+16/24215024.html si-local-file:///var/storage/secattach/20250116/24215024.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Jan+16/24215024.html Thu, 16 Jan 2025 08:30:00 -0500 O.50292072 PROC http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Jan+16/24215024.html si-local-file:///var/storage/secattach/20250116/24215024.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Jan+16/24215024.html Thu, 16 Jan 2025 08:30:00 -0500 O.50292072 PROC http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Jan+03/24166586.html si-local-file:///var/storage/secattach/20250103/24166586.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Jan+03/24166586.html Fri, 03 Jan 2025 16:15:00 -0500 O.50292072 PROC http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Jan+03/24166586.html si-local-file:///var/storage/secattach/20250103/24166586.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Jan+03/24166586.html Fri, 03 Jan 2025 16:15:00 -0500 O.50292072 PROC http://www.streetinsider.com/Press+Releases/Procaps+Group+Receives+Additional+Delinquency+Letter/24166539.html <p align="justify">MIAMI and BARRANQUILLA, Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that, as anticipated, on December 31, 2024, the Company received notice from The Nasdaq Stock Market LLC (“Nasdaq”) of an additional filing delinquency relating to the Company’s interim financial statements for the period ended June 30, 2024.</p> <p align="justify">The interim financial statements were required to be filed with Nasdaq by December 31, 2024, but were not for the reasons previously disclosed in connection with the delay http://www.streetinsider.com/Press+Releases/Procaps+Group+Receives+Additional+Delinquency+Letter/24166539.html Fri, 03 Jan 2025 16:15:00 -0500 PROC PROC http://www.streetinsider.com/Press+Releases/Procaps+Group+Receives+Additional+Delinquency+Letter/24166539.html <p align="justify">MIAMI and BARRANQUILLA, Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that, as anticipated, on December 31, 2024, the Company received notice from The Nasdaq Stock Market LLC (“Nasdaq”) of an additional filing delinquency relating to the Company’s interim financial statements for the period ended June 30, 2024.</p> <p align="justify">The interim financial statements were required to be filed with Nasdaq by December 31, 2024, but were not for the reasons previously disclosed in connection with the delay http://www.streetinsider.com/Press+Releases/Procaps+Group+Receives+Additional+Delinquency+Letter/24166539.html Fri, 03 Jan 2025 16:15:00 -0500 PROC PROC http://www.streetinsider.com/Globe+Newswire/Procaps+Group+Receives+Additional+Delinquency+Letter/24166539.html <p align="justify">MIAMI and BARRANQUILLA, Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that, as anticipated, on December 31, 2024, the Company received notice from The Nasdaq Stock Market LLC (“Nasdaq”) of an additional filing delinquency relating to the Company’s interim financial statements for the period ended June 30, 2024.</p> <p align="justify">The interim financial statements were required to be filed with Nasdaq by December 31, 2024, but were not for the reasons previously disclosed in connection with the delay http://www.streetinsider.com/Globe+Newswire/Procaps+Group+Receives+Additional+Delinquency+Letter/24166539.html Fri, 03 Jan 2025 16:15:00 -0500 PROC PROC http://www.streetinsider.com/Globe+Newswire/Procaps+Group+Receives+Additional+Delinquency+Letter/24166539.html <p align="justify">MIAMI and BARRANQUILLA, Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that, as anticipated, on December 31, 2024, the Company received notice from The Nasdaq Stock Market LLC (“Nasdaq”) of an additional filing delinquency relating to the Company’s interim financial statements for the period ended June 30, 2024.</p> <p align="justify">The interim financial statements were required to be filed with Nasdaq by December 31, 2024, but were not for the reasons previously disclosed in connection with the delay http://www.streetinsider.com/Globe+Newswire/Procaps+Group+Receives+Additional+Delinquency+Letter/24166539.html Fri, 03 Jan 2025 16:15:00 -0500 PROC PROC http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Dec+31/24155012.html si-local-file:///var/storage/secattach/20241231/24155012.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Dec+31/24155012.html Tue, 31 Dec 2024 06:02:00 -0500 O.50292072 PROC http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Dec+31/24155012.html si-local-file:///var/storage/secattach/20241231/24155012.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Dec+31/24155012.html Tue, 31 Dec 2024 06:02:00 -0500 O.50292072 PROC http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Dec+20/24133446.html si-local-file:///var/storage/secattach/20241220/24133446.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Dec+20/24133446.html Fri, 20 Dec 2024 17:00:00 -0500 O.50292072 PROC http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Dec+20/24133446.html si-local-file:///var/storage/secattach/20241220/24133446.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Procaps+Group%2C+S.A.+++++++For%3A+Dec+20/24133446.html Fri, 20 Dec 2024 17:00:00 -0500 O.50292072 PROC http://www.streetinsider.com/Press+Releases/Procaps+Group+Announces+Key+Shareholder+and+Board+Decisions%2C+Committee+Restructuring%2C+and+Leadership+Updates/24133353.html <p align="justify">MIAMI and BARRANQUILLA, Colombia, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced significant outcomes from its recent Shareholders Meeting and subsequent Board of Directors meeting. These include changes to the Board composition, restructuring of Board committees, and updates to its executive leadership team.</p> <p align="justify">The Shareholders Meeting marked an important milestone with the election of new members to the Board of Directors. The newly elected members bring a diverse range of expertise and strategic http://www.streetinsider.com/Press+Releases/Procaps+Group+Announces+Key+Shareholder+and+Board+Decisions%2C+Committee+Restructuring%2C+and+Leadership+Updates/24133353.html Fri, 20 Dec 2024 16:53:00 -0500 O.50292072 PROC http://www.streetinsider.com/Press+Releases/Procaps+Group+Announces+Key+Shareholder+and+Board+Decisions%2C+Committee+Restructuring%2C+and+Leadership+Updates/24133353.html <p align="justify">MIAMI and BARRANQUILLA, Colombia, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced significant outcomes from its recent Shareholders Meeting and subsequent Board of Directors meeting. These include changes to the Board composition, restructuring of Board committees, and updates to its executive leadership team.</p> <p align="justify">The Shareholders Meeting marked an important milestone with the election of new members to the Board of Directors. The newly elected members bring a diverse range of expertise and strategic http://www.streetinsider.com/Press+Releases/Procaps+Group+Announces+Key+Shareholder+and+Board+Decisions%2C+Committee+Restructuring%2C+and+Leadership+Updates/24133353.html Fri, 20 Dec 2024 16:53:00 -0500 O.50292072 PROC http://www.streetinsider.com/Globe+Newswire/Procaps+Group+Announces+Key+Shareholder+and+Board+Decisions%2C+Committee+Restructuring%2C+and+Leadership+Updates/24133353.html <p align="justify">MIAMI and BARRANQUILLA, Colombia, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced significant outcomes from its recent Shareholders Meeting and subsequent Board of Directors meeting. These include changes to the Board composition, restructuring of Board committees, and updates to its executive leadership team.</p> <p align="justify">The Shareholders Meeting marked an important milestone with the election of new members to the Board of Directors. The newly elected members bring a diverse range of expertise and strategic http://www.streetinsider.com/Globe+Newswire/Procaps+Group+Announces+Key+Shareholder+and+Board+Decisions%2C+Committee+Restructuring%2C+and+Leadership+Updates/24133353.html Fri, 20 Dec 2024 16:53:00 -0500 O.50292072 PROC http://www.streetinsider.com/Globe+Newswire/Procaps+Group+Announces+Key+Shareholder+and+Board+Decisions%2C+Committee+Restructuring%2C+and+Leadership+Updates/24133353.html <p align="justify">MIAMI and BARRANQUILLA, Colombia, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced significant outcomes from its recent Shareholders Meeting and subsequent Board of Directors meeting. These include changes to the Board composition, restructuring of Board committees, and updates to its executive leadership team.</p> <p align="justify">The Shareholders Meeting marked an important milestone with the election of new members to the Board of Directors. The newly elected members bring a diverse range of expertise and strategic http://www.streetinsider.com/Globe+Newswire/Procaps+Group+Announces+Key+Shareholder+and+Board+Decisions%2C+Committee+Restructuring%2C+and+Leadership+Updates/24133353.html Fri, 20 Dec 2024 16:53:00 -0500 O.50292072 PROC